Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Go back to Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
(NASDAQ: VRPX) Delayed: 0.67 --0 (-0%)
Previous Close $0.67    52 Week High
Open $0.67    52 Week Low
Day High $0.67    P/E N/A 
Day Low $0.67    EPS
Volume 6,402